• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of and finding treatments for complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia (FM), long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

Merck’s Zostavax draws new litigation from patients alleging contract Shingles 7/21/17 FiercePharma

*GG*

senior member
Messages
6,389
Location
Concord, NH
Even as Merck & Co. confronts the prospect of a tough market competitor in GlaxoSmithKline’s Shingrix, the drugmaker’s shingles vaccine Zostavax faces a growing challenge in court.

Eighteen patients have filed a liability lawsuit against Merck, alleging the company produced and sold an “unreasonably dangerous vaccine” that caused serious injuries after vaccination. Hailing from a range of states including Louisiana, South Carolina, Tennessee, Michigan and Wisconsin, the plaintiffs filed their suit in Merck’s home state of New Jersey.

cont'd

http://www.fiercepharma.com/legal/m...jbHhGdCttRkdFcm9FZ1B5VVJNeit6TU5pVFluNmpoVyJ9